Nexalin Technology, Inc. Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman – Marketscreener.com

Posted: Published on March 15th, 2024

This post was added by Dr Simmons

Nexalin Technology, Inc. announced that it has commenced sales of its second generation (Gen-2), 15 milliamp (mA) neurostimulation device into a new mental health center in Oman, dedicated to the use of Nexalin?s neurostimulation device for the treatment of patients with substance abuse disorder (SUD). The new clinic opened and commenced treatment of patients with Nexalin?s Gen-2 neurostimulation device following a successful evaluation and inspection of the facility by the Sultanate of Oman?s Ministry of Health, which ensures strict quality standards and adherence to established and robust guidelines and regulations.

Read more:
Nexalin Technology, Inc. Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman - Marketscreener.com

Related Posts
This entry was posted in Medical Technology. Bookmark the permalink.

Comments are closed.